“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.

Headline
The Centers for Medicare & Medicaid Services Oct. 23 released a proposed rule implementing new Health Insurance Marketplace eligibility verification…
Headline
The uninsured rate among working-age Americans rose to 11.2% in 2026, up from 8.9% in 2024, according to the latest biennial Commonwealth Fund survey on health…
Headline
Average annual premiums for employer-based family health coverage reached $28,303 in 2026, up 5% from 2025, according to the latest KFF annual survey on…
Headline
The Centers for Medicare & Medicaid Services Oct. 20 published two qualifying payment amount audits under the No Surprises Act. The audits were of…
Headline
The AHA has released a social media toolkit with sample posts and graphics encouraging people to sign up for 2027 health coverage via the Health Insurance…
Headline
Multiple changes to transparency in coverage requirements for insurers were finalized Oct. 5 by the Departments of the Treasury, Labor, and Health and Human…